(Q35003823)

5 August 2017

1 reference

title

Assessing disease activity and disease activity indices for inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

5 August 2017

main subject

0 references

author name string

Feng Xiao Li

series ordinal

1 reference

5 August 2017

Lloyd R Sutherland

series ordinal

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Current gastroenterology reports

5 August 2017

published in

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

490-496

1 reference

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

5 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-002-0025-Z

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-002-0025-Z

Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis

21 January 2018

1 reference

12 December 2020

Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group.

1 reference

12 December 2020

Comparison of beclomethasone dipropionate (2 and 3 mg) and prednisolone sodium phosphate enemas (30 mg) in the treatment of ulcerative proctitis. An adrenocortical approach

1 reference

12 December 2020

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

1 reference

12 December 2020

Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives

1 reference

12 December 2020

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

1 reference

12 December 2020

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

1 reference

12 December 2020

Reproducibility of colonoscopic findings in Crohn's disease: a prospective multicenter study of interobserver variation. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: study design and conduct of the study

1 reference

12 December 2020

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

12 December 2020

Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group

1 reference

12 December 2020

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1 reference

12 December 2020

A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis

1 reference

12 December 2020

The rating form of IBD patient concerns: a new measure of health status

1 reference

12 December 2020

The OMGE multinational inflammatory bowel disease survey 1976-1986. A further report on 3175 cases

1 reference

12 December 2020

Predictors of acute relapse of Crohn's disease. A laboratory and clinical study

1 reference

12 December 2020

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

12 December 2020

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

12 December 2020

Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)

1 reference

12 December 2020

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

12 December 2020

IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease

1 reference

12 December 2020

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

12 December 2020

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1 reference

12 December 2020

Measuring change over time: assessing the usefulness of evaluative instruments.

1 reference

12 December 2020

Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis.

1 reference

12 December 2020

VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS

1 reference

12 December 2020

Development and validation of a pediatric Crohn's disease activity index

1 reference

12 December 2020

Predictability of the postoperative course of Crohn's disease

1 reference

12 December 2020

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

1 reference

12 December 2020

Development of a Crohn's index for survey research

1 reference

12 December 2020

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

12 December 2020

Biopsy studies in ulcerative colitis.

1 reference

12 December 2020

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

1 reference

12 December 2020

A simple clinical index of Crohn's disease activity--the Cape Town index

1 reference

12 December 2020

Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Budesonide versus prednisolone retention enemas in active distal ulcerative colitis

1 reference

12 December 2020

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection

1 reference

12 December 2020

An index of inflammatory activity in patients with Crohn's disease

1 reference

12 December 2020

Does self-administration of a quality of life index for inflammatory bowel disease change the results?

1 reference

12 December 2020

A simple index of Crohn's-disease activity

1 reference

12 December 2020

A new measure of health status for clinical trials in inflammatory bowel disease

1 reference

12 December 2020

10.1007/S11894-002-0025-Z

Identifiers

DOI

1 reference

5 August 2017

1 reference